Visual Acuity after Retinal Gene Therapy for Choroideremia.
University of Oxford, Oxford, United Kingdom.
Thomas L
TL
Edwards
University of Oxford, Oxford, United Kingdom.
Jasleen K
JK
Jolly
University of Oxford, Oxford, United Kingdom.
Markus
M
Groppe
University of Oxford, Oxford, United Kingdom.
Alun R
AR
Barnard
Oxford Eye Hospital, Oxford, United Kingdom.
Charles L
CL
Cottriall
Imperial College London, London, United Kingdom.
Tanya
T
Tolmachova
University of Manchester, Manchester, United Kingdom.
Graeme C
GC
Black
Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Andrew R
AR
Webster
University of Southampton, Southampton, United Kingdom.
Andrew J
AJ
Lotery
Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Graham E
GE
Holder
University of Oxford, Oxford, United Kingdom.
Kanmin
K
Xue
University of Oxford, Oxford, United Kingdom.
Susan M
SM
Downes
University of Oxford, Oxford, United Kingdom.
Matthew P
MP
Simunovic
Imperial College London, London, United Kingdom.
Miguel C
MC
Seabra
University of Oxford, Oxford, United Kingdom enquiries@eye.ox.ac.uk.
Robert E
RE
MacLaren
D002386:Cataract / Q000150:complications; D015794:Choroideremia / Q000150:complications / Q000628:therapy*; D015316:Genetic Therapy; D006801:Humans; D012160:Retina; D014792:Visual Acuity